We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
+26.7%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$1.59B
AUM Growth
-$171M
Cap. Flow
-$411M
Cap. Flow %
-25.91%
Top 10 Hldgs %
89.82%
Holding
27
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$5M

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$350M
2
CELC icon
Celcuity
CELC
+$66.3M
3
CVRX icon
CVRx
CVRX
+$462K

Sector Composition

Rank Sector Weight
1 Healthcare 95.43%
2 Consumer Staples 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
26
Gossamer Bio
GOSS
$85.7M
$165K 0.01%
1,000,000
– –
ACLX
27
DELISTED
Arcellx
ACLX
– –
-3,045,262
Closed -$350M
1
2

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q2 2026 Portfolio in Review

As of Q2 2026, NEA Management Company held 27 positions worth $1.59B, down 9.7% from $1.76B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

NEA Management Company withdrew a net $411M in Q2 2026, closing 1 position and reducing 2 holdings. Its most notable exit was Arcellx, an estimated $350M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Consumer Staples.

Against the trend, NEA Management Company opened a new position in Karyopharm Therapeutics worth $5.64M.

  • NEA Management Company's largest Q2 2026 buy was Karyopharm Therapeutics: 576,780 shares worth $5.64M.
  • NEA Management Company's biggest Q2 2026 reduction was Celcuity, cutting an estimated $66.3M.
  • NEA Management Company fully exited Arcellx in Q2 2026, selling an estimated $350M.
  • NEA Management Company's ten largest holdings make up 90% of its $1.59B portfolio in Q2 2026.
  • NEA Management Company opened 1 new position and closed 1 in Q2 2026.
  • NEA Management Company's portfolio value fell 9.7% quarter-over-quarter to $1.59B.

Based on NEA Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.